"
The Beneficial Effects of Oral Cotrimoxazole upon Likely Biomarkers of Oxidative Stress in Advanced Fibrotic Lung Disease"
written by Veronica Varney, David Salisbury, Helen Parnell, Siva Ratnatheepan, Alex Nicholas, Ginny Quirke, Nazira Sumar, Amolak Bansal,
published by
Pharmacology & Pharmacy,
Vol.8 No.3, 2017
has been cited by the following article(s):
[1]
|
Protective effect of dapsone against bleomycin-induced lung fibrosis in rat
Experimental and Molecular Pathology,
2022
DOI:10.1016/j.yexmp.2021.104737
|
|
|
[2]
|
Protective effect of dapsone against bleomycin-induced lung fibrosis in rat
Experimental and Molecular Pathology,
2022
DOI:10.1016/j.yexmp.2021.104737
|
|
|
[3]
|
The Beneficial Effects of Oral Trimethoprim or Cotrimoxazole in Patients with Severe COVID-19: A Case Series
SSRN Electronic Journal ,
2020
DOI:10.2139/ssrn.3626443
|
|
|